206 related articles for article (PubMed ID: 33787131)
1. [Relationship between programmed cell death and myocardial ischemia-reperfusion injury and new perspectives of traditional Chinese medicine intervention].
Xie YZ; Ma J; Yao GZ; Zou X
Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(6):1345-1356. PubMed ID: 33787131
[TBL] [Abstract][Full Text] [Related]
2. Research Progress on the Role of Pyroptosis in Myocardial Ischemia-Reperfusion Injury.
Liu Y; Zhang J; Zhang D; Yu P; Zhang J; Yu S
Cells; 2022 Oct; 11(20):. PubMed ID: 36291138
[TBL] [Abstract][Full Text] [Related]
3. The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury.
Zhang S; Yan F; Luan F; Chai Y; Li N; Wang YW; Chen ZL; Xu DQ; Tang YP
Phytomedicine; 2024 Jul; 129():155649. PubMed ID: 38653154
[TBL] [Abstract][Full Text] [Related]
4. Research Progress of Chinese Medicine in the Treatment of Myocardial Ischemia-Reperfusion Injury.
Dong L; Shen Z; Chi H; Wang Y; Shi Z; Fang H; Yang Y; Rong J
Am J Chin Med; 2023; 51(1):1-17. PubMed ID: 36437553
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of myocardial ischemia reperfusion injury signal pathway by flavonoid monomer].
Hu YQ; Liu JH
Zhongguo Zhong Yao Za Zhi; 2023 Feb; 48(4):879-889. PubMed ID: 36872258
[TBL] [Abstract][Full Text] [Related]
6. N(6)-methyladenosine modification: A vital role of programmed cell death in myocardial ischemia/reperfusion injury.
Wang J; Li Y; Zhang S
Int J Cardiol; 2022 Nov; 367():11-19. PubMed ID: 36002042
[TBL] [Abstract][Full Text] [Related]
7. FOXN4 affects myocardial ischemia-reperfusion injury through HIF-1α/MMP2-mediated ferroptosis of cardiomyocytes.
Wang J; Deng M; Yang J; Zhou X; Yang P; Li Y; Zhang G
Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):214-225. PubMed ID: 37605566
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cell-Derived Exosomal Noncoding RNAs as Alternative Treatments for Myocardial Ischemia-Reperfusion Injury: Current Status and Future Perspectives.
Chang C; Cai RP; Su YM; Wu Q; Su Q
J Cardiovasc Transl Res; 2023 Oct; 16(5):1085-1098. PubMed ID: 37286924
[TBL] [Abstract][Full Text] [Related]
9. MiR-219a-2 relieves myocardial ischemia-reperfusion injury by reducing calcium overload and cell apoptosis through HIF1α/ NMDAR pathway.
Hu F; Zhang S; Chen X; Fu X; Guo S; Jiang Z; Chen K
Exp Cell Res; 2020 Oct; 395(1):112172. PubMed ID: 32682013
[TBL] [Abstract][Full Text] [Related]
10. Research on natural products from traditional Chinese medicine in the treatment of myocardial ischemia-reperfusion injury.
Bu W; Zhang Z; Ocansey DKW; Yu Z; Yang X; Liu Z; Wang X; Ke Y
Am J Transl Res; 2022; 14(3):1952-1968. PubMed ID: 35422902
[TBL] [Abstract][Full Text] [Related]
11. Targeting mitochondrial circadian rhythms: The potential intervention strategies of Traditional Chinese medicine for myocardial ischaemia‒reperfusion injury.
Song Z; Yang Z; Tian L; Liu Y; Guo Z; Zhang Q; Zhang Y; Wen T; Xu H; Li Z; Wang Y
Biomed Pharmacother; 2023 Oct; 166():115432. PubMed ID: 37673019
[TBL] [Abstract][Full Text] [Related]
12. Ramelteon alleviates myocardial ischemia/reperfusion injury (MIRI) through Sirt3--dependent regulation of cardiomyocyte apoptosis.
Yang Z; Xie Y; Li M; Chen W; Zhong C; Ju J; Deng Q; Wang H; Cheng T; Zhang L; Du W; Liang H
Biomed Pharmacother; 2024 Mar; 172():116229. PubMed ID: 38330708
[TBL] [Abstract][Full Text] [Related]
13. Broadening horizons: The role of ferroptosis in myocardial ischemia-reperfusion injury.
Zhao K; Chen X; Bian Y; Zhou Z; Wei X; Zhang J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2269-2286. PubMed ID: 37119287
[TBL] [Abstract][Full Text] [Related]
14. Management of ROS and Regulatory Cell Death in Myocardial Ischemia-Reperfusion Injury.
Gong G; Wan W; Zhang X; Chen X; Yin J
Mol Biotechnol; 2024 Jun; ():. PubMed ID: 38852121
[TBL] [Abstract][Full Text] [Related]
15. [Regulatory effects of traditional Chinese medicine on autophagy in myocardial ischemia reperfusion injury].
Zheng Q; Bao YM
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2925-2929. PubMed ID: 29139258
[TBL] [Abstract][Full Text] [Related]
16. [Explore molecular mechanism of Chinese herbs with promoting blood circulation and resolving phlegm effects on myocardial ischemia reperfusion injury based on correlation between microRNA and mtDNA].
Lin F; Chen HW; Shi ZL; Zhao GA; Sun YX
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):1005-1010. PubMed ID: 28994547
[TBL] [Abstract][Full Text] [Related]
17. Saponins in Chinese Herbal Medicine Exerts Protection in Myocardial Ischemia-Reperfusion Injury: Possible Mechanism and Target Analysis.
Wang R; Wang M; Zhou J; Wu D; Ye J; Sun G; Sun X
Front Pharmacol; 2020; 11():570867. PubMed ID: 33597866
[TBL] [Abstract][Full Text] [Related]
18. Research Progress on The Mechanism and Treatment of Inflammatory Response in Myocardial Ischemia-Reperfusion Injury.
Zhang D; Wu H; Liu D; Li YZ; Zhou G
Heart Surg Forum; 2022 Jun; 25(3):E462-E468. PubMed ID: 35787748
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-760-mediated low expression of DUSP1 impedes the protective effect of NaHS on myocardial ischemia-reperfusion injury.
Ren L; Wang Q; Ma L; Wang D
Biochem Cell Biol; 2020 Jun; 98(3):378-385. PubMed ID: 32160475
[TBL] [Abstract][Full Text] [Related]
20. Helix B Surface Peptide Protects against Acute Myocardial Ischemia-Reperfusion Injury via the RISK and SAFE Pathways in a Mouse Model.
Liu P; You W; Lin L; Lin Y; Tang X; Liu Y; Miao F
Cardiology; 2016; 134(2):109-17. PubMed ID: 26938973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
